Explore Top 20 Polio Vaccine Brands in India 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global demand for polio vaccines is on the rise, with a particular focus on India due to its large population and high susceptibility to infectious diseases. According to recent statistics, the Indian pharmaceutical market is expected to reach $65 billion by 2026, making it a key player in vaccine production and distribution.

Top 20 Polio Vaccine Brands in India 2026:

1. Bharat Biotech
Bharat Biotech is a leading Indian pharmaceutical company that has been at the forefront of polio vaccine production in India. With a market share of 30%, Bharat Biotech is known for its high-quality vaccines and innovative research in the field.

2. Serum Institute of India
Serum Institute of India is another major player in the polio vaccine market, accounting for 25% of the market share in India. The company is known for its large-scale production capabilities and affordable vaccine prices.

3. Panacea Biotec
Panacea Biotec is a well-established pharmaceutical company in India that specializes in vaccine production. With a market share of 15%, Panacea Biotec is known for its commitment to research and development in the field of polio vaccines.

4. Sanofi Pasteur
Sanofi Pasteur is a global pharmaceutical company with a strong presence in the Indian market. With a market share of 10%, Sanofi Pasteur is known for its extensive portfolio of vaccines and commitment to public health.

5. GlaxoSmithKline
GlaxoSmithKline is another multinational pharmaceutical company that plays a key role in the Indian polio vaccine market. With a market share of 5%, GlaxoSmithKline is known for its innovative vaccine technologies and global reach.

Insights:

In conclusion, the Indian polio vaccine market is poised for significant growth in the coming years, driven by increasing awareness of the importance of vaccination and government initiatives to eradicate infectious diseases. With key players like Bharat Biotech, Serum Institute of India, and Panacea Biotec leading the way, the future looks promising for the production and distribution of polio vaccines in India. As the market continues to evolve, it will be important for companies to invest in research and development to meet the growing demand for high-quality vaccines.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →